Search by Drug Name or NDC
NDC 50474-0500-15 Nayzilam 5 mg/.1mL Details
Nayzilam 5 mg/.1mL
Nayzilam is a NASAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by UCB, Inc.. The primary component is MIDAZOLAM.
MedlinePlus Drug Summary
Midazolam nasal spray is used for emergency situations to stop cluster seizures (episodes of increased seizure activity) in adults and children 12 years of age and older who are taking other medications to treat epilepsy (seizures). Midazolam is in a class of medications called benzodiazepines. It works by calming abnormal overactivity in the brain.
Related Packages: 50474-0500-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Midazolam Nasal Spray
Product Information
| NDC | 50474-0500 |
|---|---|
| Product ID | 50474-500_5776d86f-c632-429f-ac0b-88ade1a3930c |
| Associated GPIs | 72100060002010 |
| GCN Sequence Number | 079754 |
| GCN Sequence Number Description | midazolam SPRAY 5 MG/SPRAY NASAL |
| HIC3 | H4A |
| HIC3 Description | ANTICONVULSANT - BENZODIAZEPINE TYPE |
| GCN | 46309 |
| HICL Sequence Number | 010329 |
| HICL Sequence Number Description | MIDAZOLAM |
| Brand/Generic | Brand |
| Proprietary Name | Nayzilam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | midazolam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY |
| Route | NASAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/.1mL |
| Substance Name | MIDAZOLAM |
| Labeler Name | UCB, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA211321 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50474-0500-15 (50474050015)
| NDC Package Code | 50474-500-15 |
|---|---|
| Billing NDC | 50474050015 |
| Package | 2 BLISTER PACK in 1 CARTON (50474-500-15) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK (50474-500-14) / .1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2019-05-17 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 311.529 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | NAYZILAM 5 MG NASAL SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis